Pacific Biosciences of California, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
-0.79
Forward P/E Ratio
-4.11
PEG Ratio
0.01
-6.54
Price-to-Sales (TTM)
3.16
203.75
0.01
Market Cap
450.37M
936.71M
Is it profitable?
Net Profit Margin (TTM)
-80.35%
Gross Profit Margin
34.54%
Diluted EPS (TTM)
-0.41
-273.55%
160.03M
Is it growing?
0.10%
0.07%
Is it risky?
2.40
29.86K
5.65
706.39M
Who owns it?
54.01%
8.77%
22.18%
310.49M
303.44M
Does it pay?
0.00%
0.00%
--
--
How much cash?
275.96M
-111.84M
-48.24M
0.89
- Price
- 1.45
- Percent Change
- -0.18 (11.04%)
- Previous Close
- 1.63
- Open
- 1.60
- Low
- 1.40
- High
- 1.60
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
$1.45
From 52W Low
+46.46%
From 52W High
-46.89%
Today
-11.04%
1Y Change
+27.19%
6M
$2.32
3M
$1.38
1M
$1.71
Today
$1.45
From 52W Low
+46.46%
From 52W High
-46.89%
Today
-11.04%
1Y Change
+27.19%
6M
$2.32
3M
$1.38
1M
$1.71
Today
$1.45
Below Average
within its 1-year price range
$1.45
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-15.2%
3M
+5.1%
6M
-37.5%
1Y
+27.2%
Rate of Change (ROC)
Accelerating
Price is falling 19.0x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Pacific Biosciences of California, Inc.
- Founded
- 2000
- CEO
- Christian O. Henry
- Employees
- 485
- Fiscal Year End
- Dec 31, 2024
- Address
1305 O'Brien Drive
Menlo Park
California
94025
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.pacb.com
Indicators
Operating Cash Flow
-111.84M
Net Income
-128.58M
Backed by Cash
0.87
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |
Indicators
Operating Cash Flow
-111.84M
Net Income
-128.58M
Backed by Cash
0.87
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-0.79
Forward P/E Ratio
-4.11
PEG Ratio
0.01
-6.54
Price-to-Sales (TTM)
3.16
203.75
0.01
Market Cap
450.37M
936.71M
Is it profitable?
Net Profit Margin (TTM)
-80.35%
Gross Profit Margin
34.54%
Diluted EPS (TTM)
-0.41
-273.55%
160.03M
Is it growing?
0.10%
0.07%
Is it risky?
2.40
29.86K
5.65
706.39M
Who owns it?
54.01%
8.77%
22.18%
310.49M
303.44M
Does it pay?
0.00%
0.00%
--
--
How much cash?
275.96M
-111.84M
-48.24M
0.89
- Price
- 1.45
- Percent Change
- -0.18 (11.04%)
- Previous Close
- 1.63
- Open
- 1.60
- Low
- 1.40
- High
- 1.60
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
$1.45
From 52W Low
+46.46%
From 52W High
-46.89%
Today
-11.04%
1Y Change
+27.19%
6M
$2.32
3M
$1.38
1M
$1.71
Today
$1.45
From 52W Low
+46.46%
From 52W High
-46.89%
Today
-11.04%
1Y Change
+27.19%
6M
$2.32
3M
$1.38
1M
$1.71
Today
$1.45
Below Average
within its 1-year price range
$1.45
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-15.2%
3M
+5.1%
6M
-37.5%
1Y
+27.2%
Rate of Change (ROC)
Accelerating
Price is falling 19.0x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Pacific Biosciences of California, Inc.
- Founded
- 2000
- CEO
- Christian O. Henry
- Employees
- 485
- Fiscal Year End
- Dec 31, 2024
- Address
1305 O'Brien Drive
Menlo Park
California
94025
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.pacb.com
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |